Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AB, accredited, adhere, Aerocrine, affixed, Alison, allotment, analogize, analogy, ancillary, ARIAD, AskBio, banker, Barnard, Baxalta, BD, Beacon, Bergen, billable, BioPharma, bladder, Booth, borne, Bradford, breaking, Brunswig, Bureau, Cantor, Cardax, Cardinal, Carolina, Cascadian, CCPA, Celgene, Circassia, Circuit, Codification, Columbia, commensurate, Cox, creditworthy, cum, CVM, deadline, depository, Downstate, Durham, economy, effusion, electroCore, Elona, faith, fellowship, Fitzgerald, FTC, FTCA, GAA, genetherapy, glucosidase, GPH, Grove, Harpoon, Humacyte, implicit, Inline, inquiry, IP, JSC, King, Kingdom, Kogan, land, laude, leaving, lessor, liaison, light, medium, metastatic, NaN, noncancellable, nonessential, nontransferable, Northwestern, Ohio, onsite, Otsuka, peer, pericardial, pharmacist, POC, quantification, Rainier, RBC, reassessed, regenerative, reinforcing, remanded, ROU, round, Schecter, Scott, Seattle, Sinai, Southwestern, SQZ, stronger, SUNY, surfaced, Takeda, tariff, tolled, transposed, Twenty, UCB, UK, unchanged, unconstitutional, underwritten, unfair, unlocking, upcoming, vast, VP, weigh, widespread, worsen, Wuhan, XBRL
Removed:
accomplishment, adult, Africa, allocating, asparaginase, assured, attributed, bore, buyer, BWH, calculation, capture, CEO, chapter, checkpoint, clarify, classify, coagulation, cofactor, collectability, commonly, compound, consisted, Conversely, converted, convicted, deliverable, dietary, Earl, element, escalation, Eurasia, explain, Fabry, faculty, felony, fluctuation, focusing, galactosidase, generation, Genethon, HMS, Honor, Houston, HPV, immigrant, immunostimulatory, immunosuppression, importation, incurring, infection, inhibit, instruct, IPO, Island, joined, linked, Lonza, mark, McKinsey, microbial, microbiome, modify, modulate, monoclonal, monosodium, MUT, mutase, node, occasion, opportunistic, organic, organizing, pancreatic, Park, pegsiticase, Pennsylvania, Persuasive, Placon, postdoctoral, postgraduate, predefined, presidential, prohibited, proportional, RAC, recipient, reconciling, refinanced, refinancing, reflecting, remeasurement, remit, retroactively, revaluation, robust, RUSNANOPRIZE, satisfying, seasoned, seller, sequence, shell, simulate, skin, societal, SPA, SRN, stimulate, stimulating, sublicensing, substitute, summarize, SVP, tolerant, tool, TPE, transplantation, trichloroethylene, vi, visualize, VSOE, Werner, wild, worthy
Filing tables
Filing exhibits
Related press release
Associated RNAC transcripts
RNAC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8, File No. 333-212215) pertaining to the 2008 Stock Incentive Plan, as amended, the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Selecta Biosciences, Inc., |
(2) | Registration Statement (Form S-8, File No. 333-224109) pertaining to the 2016 Incentive Awards Plan and the 2016 Employee Stock Purchase Plan, |
(3) | Registration Statement (Form S-8, File No. 333-228264) pertaining to the 2018 Employment Inducement Incentive Award Plan, |
(4) | Registration Statement (Form S-8, File No. 333-230501) pertaining to the 2018 Employment Inducement Incentive Award Plan, |
(5) | Registration Statement (Form S-3, File No. 333-219262), |
(6) | Registration Statement (Form S-3, File No. 333-219900), and |
(7) | Registration Statement (Form S-3, File No. 333-236147); |
of our report dated March 12, 2020 with respect to the consolidated financial statements of Selecta Biosciences, Inc. included in this Annual Report (Form 10-K) of Selecta Biosciences, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 12, 2020